Skip to main content
CDC Website

World Health Organization

A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities

This book was developed to assist in the management of TB and HIV/AIDS programs that are implementing or planning to implement collaborative TB/HIV activities. It is intended to facilitate the collection of standardized data and help in the interpretation and dissemination of these data for program improvement. It aims to ensure consistency across all agencies and stakeholders involved in HIV/AIDS, TB, and collaborative TB/HIV activities.

DOTS-Plus and Green Light Committee

This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.

How Human Immunodeficiency Virus Voluntary Testing Can Contribute to Tuberculosis Control

This report sets out the rationale for the ProTest Initiative (Promotion of Voluntary Testing), based on an analysis of the impact of HIV on TB control. It describes the elements of the ProTest approach, reviews progress so far, and sets out the future direction. The purpose of the report is to generate discussion and ideas that will help the Initiative establish a comprehensive range of interventions needed to control TB in settings with high prevalence of HIV infection.

Guideline: Updates on HIV and Infant Feeding

WHO guidelines on HIV and Infant Feeding in 2010 for the first time recommended the use of antiretroviral drugs to prevent postnatal transmission of HIV through breastfeeding. This resulted in a major change from an individualised counselling approach toward a public health approach regarding how maternal and child health services should routinely promote and support infant feeding practices among mothers living with HIV

Comprehensive Cervical Cancer Control: A Guide to Essential Practice

This guide includes WHO recommendations on screening and treatment of pre-cancer lesions and on HPV vaccination made through April 2014, taking account of relevant evidence-based findings published up to December 2013; emerging practices that are still being evaluated are also noted in this publication. This guide, which replaces the 2006 edition, has two new chapters, one newly organized chapter, and two substantially revised chapters. The new chapters include: Essentials for cervical a=cancer prevention and control programmes; and HPV vaccination.